Skip to Main Content

Paper Details

Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH.
Cell Death Differ
56
2020
NAFLD, NASH, Nonalcoholic fatty liver disease, Slc25a1, Slc25a1 gene, chronic liver damage, citrate, diabetes, fatty liver disease, gluconeogenic genes, glucose, glucose intolerance, hyperglycemia, inflammation, inflammatory macrophage, inflammatory steatohepatitis, metabolic syndrome, mitochondrial citrate carrier, obesity, peroxisome proliferator-activated receptor gamma, steatohepatitis, steatosis
Author NameAffiliation
Garrett T GrahamGeorgetown University Medical Center, Lombardi Comprehensive Cancer Center
Giuseppe GiacconeGeorgetown University Medical Center, Lombardi Comprehensive Cancer Center
Giuseppe GiacconeGeorgetown University Medical Center, Lombardi Comprehensive Cancer Center
Amrita K CheemaGeorgetown University Medical Center, Lombardi Comprehensive Cancer Center
Bhaskar KallakuryGeorgetown University Medical Center, Lombardi Comprehensive Cancer Center
  • 1 - 5

Datasets

Release 1.2